F. Ann Millner Sells 3,780 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 3,780 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $36.67, for a total value of $138,612.60. Following the transaction, the director now owns 13,298 shares in the company, valued at approximately $487,637.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

MMSI stock traded down $1.11 during midday trading on Monday, hitting $35.07. 797,200 shares of the company’s stock were exchanged, compared to its average volume of 456,322. The business has a 50-day simple moving average of $47.65 and a two-hundred day simple moving average of $55.25. The company has a current ratio of 2.42, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $2.03 billion, a PE ratio of 20.75, a P/E/G ratio of 1.74 and a beta of 1.03. Merit Medical Systems, Inc. has a 1-year low of $35.00 and a 1-year high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.08). The business had revenue of $255.50 million for the quarter, compared to analyst estimates of $258.58 million. Merit Medical Systems had a return on equity of 10.40% and a net margin of 4.10%. Merit Medical Systems’s revenue was up 13.7% compared to the same quarter last year. During the same period last year, the business earned $0.43 EPS. As a group, research analysts expect that Merit Medical Systems, Inc. will post 1.79 EPS for the current fiscal year.



MMSI has been the topic of a number of analyst reports. Piper Jaffray Companies set a $58.00 price objective on Merit Medical Systems and gave the stock an “overweight” rating in a research report on Friday, July 26th. Wells Fargo & Co downgraded Merit Medical Systems from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $71.00 to $46.00 in a research report on Friday, July 26th. Canaccord Genuity reduced their price objective on Merit Medical Systems from $63.00 to $53.00 and set a “buy” rating on the stock in a research report on Friday, July 26th. Zacks Investment Research upgraded Merit Medical Systems from a “sell” rating to a “hold” rating and set a $63.00 price objective on the stock in a research report on Monday, July 1st. Finally, Needham & Company LLC downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, July 26th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $61.75.

Hedge funds have recently bought and sold shares of the business. Royal Bank of Canada boosted its holdings in Merit Medical Systems by 60.0% in the second quarter. Royal Bank of Canada now owns 309,235 shares of the medical instruments supplier’s stock valued at $18,417,000 after purchasing an additional 115,929 shares during the period. Amundi Pioneer Asset Management Inc. boosted its holdings in Merit Medical Systems by 5.9% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 76,800 shares of the medical instruments supplier’s stock valued at $4,575,000 after purchasing an additional 4,300 shares during the period. United Services Automobile Association boosted its holdings in Merit Medical Systems by 4.9% in the second quarter. United Services Automobile Association now owns 13,493 shares of the medical instruments supplier’s stock valued at $804,000 after purchasing an additional 631 shares during the period. Waddell & Reed Financial Inc. lifted its holdings in Merit Medical Systems by 7.7% during the 2nd quarter. Waddell & Reed Financial Inc. now owns 862,203 shares of the medical instruments supplier’s stock worth $51,353,000 after buying an additional 61,358 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its holdings in Merit Medical Systems by 1,385.8% during the 2nd quarter. Nuveen Asset Management LLC now owns 401,400 shares of the medical instruments supplier’s stock worth $23,908,000 after buying an additional 374,384 shares during the last quarter. 97.19% of the stock is owned by institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Read More: Are we seeing the beginning of a new bubble?

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.